You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

CLINICAL TRIALS PROFILE FOR LIXIVAPTAN


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for Lixivaptan

Trial ID Title Status Sponsor Phase Summary
NCT00578695 ↗ THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation Completed Biogen Phase 3 The purpose of this study is to determine the safety and efficacy of lixivaptan in the treatment of hyponatremia in patients with congestive heart failure.
NCT00578695 ↗ THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation Completed Cardiokine Biopharma, LLC Phase 3 The purpose of this study is to determine the safety and efficacy of lixivaptan in the treatment of hyponatremia in patients with congestive heart failure.
NCT00578695 ↗ THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation Completed CardioKine Inc. Phase 3 The purpose of this study is to determine the safety and efficacy of lixivaptan in the treatment of hyponatremia in patients with congestive heart failure.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Lixivaptan

Condition Name

Condition Name
Intervention Trials
Polycystic Kidney Disease, Adult 3
Autosomal Dominant Polycystic Kidney Disease 1
Congestive Heart Failure 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH
Intervention Trials
Polycystic Kidney Diseases 5
Kidney Diseases 5
Hyponatremia 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lixivaptan

Trials by Country

Trials by Country
Location Trials
United States 118
India 22
Poland 4
Canada 4
Russian Federation 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State
Location Trials
California 6
Pennsylvania 6
North Carolina 5
New York 5
Missouri 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lixivaptan

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase Trials
Phase 3 7
Phase 2 2
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase Trials
Completed 6
Recruiting 2
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lixivaptan

Sponsor Name

Sponsor Name
Sponsor Trials
Cardiokine Biopharma, LLC 6
CardioKine Inc. 6
Biogen 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type
Sponsor Trials
Industry 22
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.